Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 17;22(1):e1004515.
doi: 10.1371/journal.pmed.1004515. eCollection 2025 Jan.

Roll out and prospects of the malaria vaccine R21/Matrix-M

Lorenz von Seidlein  1   2
Affiliations

Roll out and prospects of the malaria vaccine R21/Matrix-M

Lorenz von Seidlein. PLoS Med. .

Abstract

In this Perspective article, Lorenz von Seidlein outlines the promise of two malaria vaccines, and discusses some of the considerations for their roll out.

PubMed Disclaimer

Conflict of interest statement

I have read the journal’s policy and the authors of this manuscript have the following competing interests: 1) My colleagues and I have been and are currently conducting trials with R21/Matrix-M. 2) the author is an Academic Editor for PLOS Medicine.

References

    1. Collins KA, Snaith R, Cottingham MG, Gilbert SC, Hill AVS. Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine. Sci Rep. 2017;7:46621. Epub 2017/04/20. doi: 10.1038/srep46621 ; PubMed Central PMCID: PMC5395940. - DOI - PMC - PubMed
    1. Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, et al.. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med. 2011;365(20):1863–75. Epub 2011/10/20. doi: 10.1056/NEJMoa1102287 . - DOI - PubMed
    1. Chandramohan D, Zongo I, Sagara I, Cairns M, Yerbanga RS, Diarra M, et al.. Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. N Engl J Med. 2021;385(11):1005–17. Epub 2021/08/26. doi: 10.1056/NEJMoa2026330 . - DOI - PubMed
    1. Datoo MS, Dicko A, Tinto H, Ouedraogo JB, Hamaluba M, Olotu A, et al.. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet. 2024;403(10426):533–44. Epub 2024/02/05. doi: 10.1016/S0140-6736(23)02511-4 . - DOI - PubMed
    1. UKRI. ICF: Seasonal R21 mass vaccination for malaria elimination. https://gtrukriorg/projects?ref=MR%2FY00468X%2F1. 2024.

MeSH terms

Substances